My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,076.98 +5.34 (+0.50%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Why Eli Lilly (LLY) Stock Is Trading Up Today

August 11, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after the stock rebounded following a decline the previous week. The stock had dropped sharply the...

Via StockStory

Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts ↗

August 11, 2025

A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict 340B drug discounts for safety-net clinics, sending the case back to...

Via Benzinga

Topics Lawsuit

3 Top Stocks to Load Up on After Earnings ↗

August 11, 2025

Here are three stocks to buy now that could offer investors upside in the short and long terms.

Via The Motley Fool

Gartner, Eli Lilly, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (August 4-August 8): Are The Others In Your Portfolio? ↗

August 10, 2025

Large-cap laggards slid on weak results/guidance, cuts and capital moves—led by The Trade Desk, Fortinet, Super Micro, Gartner and Eli Lilly.

Via Benzinga

ETFs In Focus On Eli Lilly's Solid Q2 Earnings, Weak Obesity Data ↗

August 09, 2025

Eli Lilly and Company reported robust second-quarter 2025 results, wherein it beat estimates on both the top and bottom lines. However, shares of Eli Lilly stock tumbled 14%. Here are ETFs with...

Via Talk Markets

Topics ETFs

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly ↗

August 09, 2025

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

Via MarketBeat

Topics Government World Trade

Benzinga Bulls And Bears: AMD, Apple, Eli Lilly — And Wall Street Treads Water ↗

August 09, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Trump's Gold Tariffs Shake Markets, Eli Lilly Plunges, Oil Dips On US-Russia Deal, Jobs Miss Fuels Recession Fears — This Week In Economy ↗

August 09, 2025

The past week saw market turbulence, with President Trump's new gold tariffs, Eli Lilly's dramatic stock drop, a weakening jobs report fueling recession fears, and a divided Federal Reserve debating...

Via Benzinga

Topics Economy Government World Trade

Why Novo Nordisk Stock Flew Higher on Friday ↗

August 08, 2025

It looked good next to a company that has been stealing its thunder lately.

Via The Motley Fool

Why Eli Lilly Stock Sank 18% This Week ↗

August 08, 2025

The drugmaker is in a 35% drawdown.

Via The Motley Fool

Topics World Trade

Apple Notches Best Week In Years, Trump Shakes Fed Leadership: This Week In Markets ↗

August 08, 2025

After a dip last week, Wall Street rebounded as earnings remained strong. Tech stocks surged, but Eli Lilly struggled. Trump imposed tariffs on India and nominated Stephen Miran for Fed seat.

Via Benzinga

Topics Economy Government World Trade

Wall Street's Resilient Rally: What's Driving the Positive Momentum

August 08, 2025

Wall Street has experienced a broadly positive day, marked by a resilient rally that has added over $1 trillion in market value. This surge in investor confidence is primarily driven by a confluence of...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

Expert Outlook: Eli Lilly Through The Eyes Of 4 Analysts ↗

August 08, 2025

Via Benzinga

Eli Lilly's Orforglipron Data Is Not Disastrous: Analyst ↗

August 08, 2025

Eli Lilly's orforglipron missed weight loss targets in a Phase 3 trial, but strong Q2 results and raised guidance highlight the company's growth strength.

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

August 08, 2025

Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.

Via Chartmill

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? ↗

August 08, 2025

Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.

Via MarketBeat

SoundHound Stock Rallies On Huge Revenue Jump ↗

August 08, 2025

SoundHound stock rallied Friday after the conversational AI technology company posted a huge gain in revenue.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Does This $856 Million Investment Make Eli Lilly Stock a Buy? ↗

August 08, 2025

The drugmaker continues to grab headlines for all the right reasons.

Via The Motley Fool

Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried? ↗

August 08, 2025

Eli Lilly has normally been a market-beating stock, but not this year.

Via The Motley Fool

Topics Economy World Trade

Apple's $704 Billion Decade-Long Buybacks Exceed Market Cap Of All But 13 Companies Worldwide ↗

August 08, 2025

Apple's $704B in buybacks over 10 years exceeds the market cap of 488 S&P 500 firms. Learn why it still avoids major acquisitions.

Via Benzinga

Topics Stocks

Stock Market Today: S&P 500, Nasdaq 100 Futures Rise As Trump Appoints New Fed Governor—Beauty Health, RealReal, Twilio In Focus On Q2 Earnings ↗

August 08, 2025

U.S. stock futures rose on Friday after ending on a mixed note on Thursday. Futures of major benchmark indices were higher.

Via Benzinga

Topics Economy Government Stocks

Novo Nordisk Stock Climbs Over 4% In Friday Pre-Market: What's Going On? ↗

August 08, 2025

Novo Nordisk A/S climbed 3.72% during Friday's pre-market trading session, after rival Eli Lily 's Phase 3 ATTAIN-1 trial for obesity drug, orforglipron trailed the Danish drug giant's semaglutide.

Via Benzinga

Dow Tumbles Over 200 Points Following Earnings Reports: Fear & Greed Index Remains In 'Neutral' Zone ↗

August 08, 2025

CNN's Fear & Greed Index declined but remained in Neutral zone on Thursday. Dow fell 200 points, while Apple, Eli Lilly reported earnings.

Via Benzinga

Topics Stocks

Market Monitor News August 08 BMO - Tariffs, Tablets, and Turbulence: Wall Street Sways Under Trade War Fears and Pharma Fallout ↗

August 08, 2025

Wall Street ended Thursday on a shaky note as disappointing drug trial results, new trade tariffs, and cautious corporate guidance weighed on sentiment. While Apple (AAPL | +3.2%) basked in the glow of...

Via Chartmill

Topics World Trade

The Trade Desk, SoundHound AI, Eli Lilly, Block And CrowdStrike: Why These 5 Stocks Are On Investors' Radars Today ↗

August 07, 2025

The U.S. stock market saw a mixed performance today, with the Nasdaq gaining over 70 points, reflecting a 0.35% increase to 21,242.70

Via Benzinga

Topics Artificial Intelligence

Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound ↗

August 07, 2025

Via Stocktwits

Eli Lilly Stock Sell-Off ‘Overdone’ As Weight-Loss Pill Remains ‘Commercially Viable’ ↗

August 07, 2025

Eli Lilly's late-stage data for weight-loss pill falls short of expectations.

Via Talk Markets

Eli Lilly Shares Tumble After Disappointing Weight-Loss Pill Data

August 07, 2025

Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a dramatic decline today, plummeting by more than 14% in early trading, wiping out approximately $98...

Via MarketMinute

Will Gilead's Beat-And-Raise Help It Leapfrog Its 50-Day Line Ceiling? ↗

August 07, 2025

Gilead Sciences boosted its full-year outlook after beating expectations. Gilead stock is hitting a 50-day line ceiling.

Via Investor's Business Daily

Why Eli Lilly (LLY) Shares Are Getting Obliterated Today

August 07, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss drug trial results disappointed investors, overshadowing an otherwise strong...

Via StockStory

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.